Skip to main content

Advertisement

SpringerLink
Log in

Total Skin-Sparing Mastectomy in BRCA Mutation Carriers

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Total skin-sparing mastectomy (TSSM) with preservation of the nipple–areolar complex skin has become increasingly accepted as an oncologically safe procedure. Oncologic outcomes after TSSM in BRCA mutation carriers have not been well-studied.

Methods

We identified 53 BRCA-positive patients who underwent bilateral TSSM for prophylactic (26 patients) or therapeutic indications (27 patients) from 2001 to 2011. Cases were age-matched (for prophylactic cases) or age- and stage-matched (for therapeutic cases) with non-BRCA-positive patients. Outcomes included tumor involvement of resected nipple tissue, the development of new breast cancers in patients who underwent risk-reducing TSSM, and local–regional recurrence in patients who underwent therapeutic TSSM.

Results

Outcomes from 212 TSSM procedures in 53 cases and 53 controls were analyzed. In patients undergoing TSSM for prophylactic indications, in situ cancer was found in one (1.9 %) nipple specimen in BRCA-positive patients versus two specimens (3.8 %) in the non-BRCA-positive cohort (p = 1). At a mean follow-up of 51 months, no new cancers developed in either cohort. In patients undergoing TSSM for therapeutic indications, in situ or invasive cancer was found in zero of the nipple specimens in BRCA-positive patients versus two specimens (3.7 %) in the non-BRCA-positive cohort (p = 0.49). At a mean follow-up of 37 months, there were no local–regional recurrences in the BRCA-positive cohort and 1 (3.7 %) in the non-BRCA-positive cohort.

Conclusions

TSSM is an oncologically safe procedure in BRCA-positive patients. In patients undergoing TSSM as a risk-reducing strategy, 4-year follow-up demonstrates no increased risk of developing new breast cancers; longer-term follow-up is ongoing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Peled AW, Foster RD, Stover AC, et al. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol. 2012;19:3402–9.

    Article  Google Scholar 

  2. Stolier AJ, Levine EA. Reducing the risk of nipple necrosis: technical observations in 340 nipple-sparing mastectomies. Breast J. 2013;19:173–9.

    Article  PubMed  Google Scholar 

  3. Piper M, Peled AW, Foster RD, Moore DH, Esserman LJ. Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg. 2013;70:435–7.

    Article  CAS  Google Scholar 

  4. Peled AW, Foster RD, Garwood ER, et al. The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg. 2012;129:901e–8e.

    Article  CAS  PubMed  Google Scholar 

  5. Algaithy ZK, Petit JY, et al. Nipple-sparing mastectomy: can we predict the factors predisposing to necrosis? Eur J Surg Oncol. 2012;38:125–9.

    Article  CAS  PubMed  Google Scholar 

  6. Peled AW, Duralde E, Stover AC, Sbitany H, Esserman LJ, Foster RD. Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. In: Plastic Surgery Research Council annual meeting. Santa Monica, May 2013.

  7. Djohan R, Gage E, Gatherwright J, et al. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010;125:818–29.

    Article  CAS  PubMed  Google Scholar 

  8. Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118:623–33.

    Article  CAS  PubMed  Google Scholar 

  9. Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.

    Article  PubMed  Google Scholar 

  10. Garcia-Etienne CA, Cody III HS, et al. Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature. Breast J. 2009;15:440–9.

    Article  PubMed  Google Scholar 

  11. Spear SL, Willey SC, Feldman ED, et al. Nipple-sparing mastectomy for prophylactic and therapeutic indications. Plast Reconstr Surg. 2011;128:1005–14.

    Article  CAS  PubMed  Google Scholar 

  12. Alcantara Filho P, Capko D, Barry JM, Morrow M, Pusic A, Sacchini VS. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience. Ann Surg Oncol. 2011;18:3117–22.

    Article  PubMed  Google Scholar 

  13. Stolier AJ, Sullivan SK, Dellacroce FJ. Technical considerations in nipple-sparing mastectomy: 82 consecutive cases without necrosis. Ann Surg Oncol. 2008;15:1341–7.

    Article  PubMed  Google Scholar 

  14. Reynolds C, Davidson JA, Lindor NM, et al. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved? Ann Surg Oncol. 2011;18:3102–9.

    Article  PubMed  Google Scholar 

  15. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304:967–75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633–7.

    Article  CAS  PubMed  Google Scholar 

  17. Brachtel EF, Rusby JE, Michaelson JS, et al. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. J Clin Oncol. 2009;27:4948–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Plastic and Reconstructive Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

    Anne Warren Peled MD & Chetan S. Irwin MD

  2. Division of Breast Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA

    E. Shelley Hwang MD

  3. Division of Breast Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA

    Cheryl A. Ewing MD, Michael Alvarado MD & Laura J. Esserman MD

Authors
  1. Anne Warren Peled MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chetan S. Irwin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Shelley Hwang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cheryl A. Ewing MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Alvarado MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laura J. Esserman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura J. Esserman MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peled, A.W., Irwin, C.S., Hwang, E.S. et al. Total Skin-Sparing Mastectomy in BRCA Mutation Carriers. Ann Surg Oncol 21, 37–41 (2014). https://doi.org/10.1245/s10434-013-3230-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3230-0

Keywords

Search

Navigation